Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Whats New LAL-D

    Launch of LAL-D Knowledge Centre

    A new educational resource on lysosomal acid lipase deficiency is
    now available to epgonline.org users. Content highlights include latest
    disease awareness facts and statistics, important treatment information and
    a video channel comprising expert discussions on topics such
    as diagnostic approach and current prognosis.

  • ,CSU news case studies 2016

    Updates to the Chronic Spontaneous
    Urticaria Knowledge Centre

    Case studies from urticaria experts Professor Christian Vestergaard
    and Professor Torsten Zuberbier have been added to the ‘Case Studies
    section of the Chronic Spontaneous Urticaria Knowledge Centre.
    Additionally, this resource has been updated with information
    on the TARGET My Hives app and refreshed with a whole new look and feel.

  • ,OAC Reversal Whats New 2

    Launch of Oral Anticoagulation Reversal Knowledge Centre

    This new resource provides healthcare professionals with accurate information on the approaches
    to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding,
    or require surgery. View illustrated and referenced sections on management of bleeding, oral
    anticoagulants, symposium highlights, key publications commentary and more. This resource is
    developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with
    content provided by CSL Behring.

    This resource is not intended for healthcare professionals outside Europe.

  • ,Hypogonadism Relaunch Whats New

    Launch of updated Hypogonadism Knowledge Centre

    Our Hypogonadism Knowledge Centre contains important disease awareness
    information to support healthcare professionals in the current best practice
    treatment and management of male hypogonadism and is available to access free of
    charge. Sections cover epidemiology, pathophysiology, signs and symptoms, treatment
    options, as well as useful resources and a regularly updated publications digest.

    G.MKT.GM.MH.01.2016.0364

  • ,Cystic Fibrosis Knowledge Centre

    Launch of the Cystic Fibrosis Knowledge Centre

    This new resource has been developed to support healthcare professionals
    in the treatment of patients with cystic fibrosis (CF).
    It contains a host of clinical information including a disease awareness section,
    emerging and supportive therapeutic options and current best practice
    based on recently updated guidelines by the
    European Cystic Fibrosis Society (ECFS).

Latest News

Phase III data for HDM sublingual allergy immunotherapy tablet Acarizax for house dust mite allergy published in Journal of the American Medical Association- ALK

29-Apr-2016

ALK has announced that The Journal of the American Medical Association (JAMA) has published results from a Phase III clinical trial evaluating the treatment of house dust mite (HDM) allergic asthma with the company's HDM sublingual allergy ...

NICE recommends Entresto (sacubitril + valsartan) to treat chronic heart failure.-Novartis

29-Apr-2016

The National Institute for Health and Care Excellence (NICE) has recommended in final draft guidance Entresto (sacubitril + valsartan) from Novartis as an option for treating symptomatic chronic heart failure with reduced ejection fraction in adult ...

Clinical results presented for Nellix EndoVascular Aneurysm Sealing System in abdominal aortic aneurysms- Endologix

29-Apr-2016

Endologix announced the presentation of positive clinical data for the Nellix EndoVascular Aneurysm Sealing System, including updated data from the Nellix EVAS-FORWARD – Global Registry. Global Registry data includes a total of 300 patients with a ...

Phase III TOURMALINE-MM1 results for Ninlaro (ixazomib) in multiple myeloma published in NEJM- Takeda

29-Apr-2016

Takeda has announced that results from the international, randomized, double-blind, placebo-controlled TOURMALINE-MM1 Phase III clinical study, evaluating once-weekly oral Ninlaro (ixazomib) capsules plus lenalidomide and dexamethasone versus placebo ...

Two phase III trials of SUN 101/eFlow (glycopyrrolate) met primary endpoints in severe chronic obstructive pulmonary disease- Sunovion

29-Apr-2016

Sunovion has announced positive results from the Phase III clinical trial program for SUN-101 (glycopyrrolate), a nebulized long-acting muscarinic antagonist (LAMA), delivered via PARI’s innovative investigational eFlow nebulizer system ...

EMA approves Lonsurf (trifluridine/tipiracil) for metastatic colorectal cancer- Taiho Pharmaceutical/Servier

29-Apr-2016

The European Commission (EC) has granted marketing authorization for Lonsurf (trifluridine/tipiracil), formerly known as TAS-102, from Taiho Pharmaceutical Co, in the European Union for the treatment of adult patients with metastatic colorectal ...

AbbVie to acquire Stemcentrx and with it rovalpituzumab tesirine (Rova-T) treatment for small cell lung cancer

29-Apr-2016

AbbVie has announced that it will acquire Stemcentrx and its lead late-stage asset rovalpituzumab tesirine (Rova-T) currently in registrational trials for small cell lung cancer (SCLC). Rova-T is a novel biomarker-specific therapy that is derived ...

Recent Updates

Drugs

Clinical Guidelines

Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

2015 UK national guideline for the management of infection with Chlamydia trachomatis

Blood grouping and antibody testing in pregnancy

Fractures (complex): assessment and management

Medical Journals

Psoriasis

Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.

Imatinib: a breakthrough of targeted therapy in cancer.

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages

News

News

News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors